drugset / Trial / NCT00608062

Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

NCT00608062

RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to find out why women's arteries stiffen as they go through menopause, and how this is affected by estrogen loss. We believe that arteries stiffen with the loss of estrogen because of "oxidative stress," the production of molecules that can damage cells and tissues in the body, and because the arteries lose their ability to expand, or dilate.

Timeline

Start
2007-03
Primary completion
2012-10-25
Completion
2012-10-25

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 0.075 mg Other
Background Ganirelix Protein / enzyme biologic 0.25 mg Subcutaneous